Cw. Sachs et al., EFFECTS OF SPHINGOSINE STEREOISOMERS ON P-GLYCOPROTEIN PHOSPHORYLATION AND VINBLASTINE ACCUMULATION IN MULTIDRUG-RESISTANT MCF-7 CELLS, Biochemical pharmacology, 52(4), 1996, pp. 603-612
To investigate the role of protein kinase C (PKC) in the regulation of
multidrug resistance and P-glycoprotein (P-gp) phosphorylation, the n
atural isomer of sphingosine (SPH), D-erythro sphingosine (De SPH), an
d its three unnatural stereoisomers were synthesized. The SPH isomers
showed similar potencies as inhibitors of in vitro PKC activity and ph
orbol binding, with IC50 values of approximately 50 mu M in both assay
s. Treatment of multidrug-resistant MCF-7(ADR) cells with SPH stereois
omers increased vinblastine (VLB) accumulation up to 6-fold at 50 mu M
but did not alter VLB accumulation in drug-sensitive MCF-7 wild-type
(WT) cells or accumulation of 5-fluorouracil in either cell line. Phor
bol dibutyrate treatment of MCF-7(ADR) cells increased phosphorylation
of P-gp, and this increase was inhibited by prior treatment with SPH
stereoisomers. Treatment of MCF-7(ADR) cells with SPH stereoisomers de
creased basal phosphorylation of the P-gp, suggesting inhibition of PK
C-mediated phosphorylation of P-gp. Most drugs that are known to rever
se multidrug resistance, including several PKC inhibitors, have been s
hown to directly interact with P-gp and inhibit drug binding. SPH ster
eoisomers did not inhibit specific binding of [H-3] VLB to MCF-7(ADR)
cell membranes or [3H]azidopine photoaffinity labeling of P-gp or alte
r P-gp ATPase activity. These results suggest that SPH isomers are not
substrates of P-gp and suggest that modulation of VLB accumulation by
SPH stereoisomers is associated with inhibition of PKC-mediated phosp
horylation of P-gp.